Portman Square Capital’s Humana HUM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-6,712
Closed -$1.7M – 295
2024
Q4
$1.7M Buy
6,712
+2,317
+53% +$621K 0.06% 191
2024
Q3
$1.39M Buy
4,395
+2,199
+100% +$783K 0.05% 249
2024
Q2
$821K Sell
2,196
-2,577
-54% -$870K 0.03% 289
2024
Q1
$1.65M Buy
4,773
+3,707
+348% +$1.4M 0.05% 213
2023
Q4
$488K Buy
+1,066
New +$525K 0.01% 390
2023
Q1
– Sell
-1,596
Closed -$817K – 343
2022
Q4
$817K Buy
+1,596
New +$839K 0.06% 216

Other funds holding HUM

Portman Square Capital's HUM Position: Q1 2025 in Review

Portman Square Capital sold out of Humana (HUM) in Q1 2025, closing a stake of 6,712 shares — an estimated $1.7M sold.

Portman Square Capital first reported a position in HUM in Q4 2022 and held it in 6 quarters. The position peaked at $1.7M in Q4 2024. 903 funds tracked by Wall St. Rank hold HUM as of Q1 2025.

  • Portman Square Capital reported no remaining Humana position as of Q1 2025 after selling out during the quarter.
  • Portman Square Capital sold 6,712 Humana shares in Q1 2025, an estimated $1.7M.
  • Portman Square Capital first reported a position in Humana in Q4 2022 and held it in 6 quarters.
  • Portman Square Capital's Humana position peaked at $1.7M in Q4 2024.
  • 903 funds tracked by Wall St. Rank held Humana as of Q1 2025.

Based on Portman Square Capital's 13F filing for Q1 2025, filed 2 May 2025.